Grandfather Battles Stage 3 Pancreatic Cancer with Clinical Trial

Hernando Salcedo, a 68‑year‑old grandfather from Miami, faced a daunting Stage 3 pancreatic cancer diagnosis after only mild symptoms. Traditional chemotherapy left him feeling worse than before, but a new clinical trial offered a lifeline that changed his outlook and treatment trajectory.

From Mild Symptoms to a Life‑Changing Diagnosis

Salcedo’s journey began with subtle discomfort—an occasional ache in his abdomen and fatigue that he initially attributed to aging. A routine check‑up, however, revealed a tumor in the pancreas, prompting a rapid referral to a specialized oncology center. The cancer had already progressed to Stage 3, a stage where the tumor had spread beyond the pancreas but had not yet reached distant organs.

Chemotherapy’s Toll and the Search for Alternatives

Standard chemotherapy regimens, while often effective, can be brutal. Salcedo experienced severe nausea, hair loss, and a profound decline in energy levels. “I felt like I was losing myself,” he said. The side effects not only impacted his physical health but also his ability to care for his grandchildren and maintain his daily routine.

Enter the Renovocath Clinical Trial

During a conversation with his oncologist, Salcedo learned about a promising clinical trial involving a novel drug called Renovocath, designed to target pancreatic cancer cells more precisely. The trial, conducted at a leading Miami research facility, offered a chance to receive a treatment that could potentially shrink the tumor while sparing healthy tissue.

“It felt like a second chance,” Salcedo recalled. The trial protocol included a combination of the new drug with a reduced dose of traditional chemotherapy, aiming to balance efficacy with tolerability.

Early Results and a Renewed Optimism

After several weeks of treatment, imaging studies showed a noticeable reduction in tumor size. Salcedo’s energy levels improved, and he reported fewer side effects compared to his previous chemotherapy course. While the trial is ongoing, these early outcomes have given him and his family renewed hope.

What This Means for Pancreatic Cancer Patients

Salcedo’s experience underscores the importance of clinical trials in advancing cancer care. For patients facing aggressive cancers like Stage 3 pancreatic cancer, trials can offer access to cutting‑edge therapies that are not yet widely available.

“If you’re in a similar situation, talk to your doctor about clinical trials,” Salcedo advised. “It’s about exploring every possible avenue to improve your chances.”

For more details on the Renovocath trial and how to find clinical studies in your area, visit the CBS News article.

Watch and listen free on JASTORM – Follow radio and video broadcasts free in the JASTORM app with your free account.